UChicago Annual Updates from ASH 2019
Updates on Myeloid Malignancies: JAK in MF, TGFb Inhibition in MF and MDS & Oral Azanucleosides in AML and MDS & IDH Inhibitors in AML & MPN
By
UChicago Annual Updates from ASH 2019
FEATURING
Olatoyosi Odenike
By
UChicago Annual Updates from ASH 2019
FEATURING
Olatoyosi Odenike
Login to view comments.
Click here to Login